secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001140361-24-009930
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano amends convertible debt deal, redeems $27.7M of notes, cuts liquidity covenant to $25M
--------------------------------------------------------------------------------

- Redeems entire $17M outstanding principal of Initial Private Placement Note at 115% for $19.55M; plus $1M increase to retirement fee.
- Redeems $10.663M of Initial Registered Note at 115% for $12.26M; $24.337M principal remains outstanding.
- Minimum liquidity covenant reduced from $50M to $25M; restricted cash requirement cut from $35M to $25M.
- March 2024 partial redemption canceled; April payment delayed from April 1 to April 20, 2024.
- Company gains immediate access to $30M in near-term liquidity, with up to $25M more as principal is retired.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124009930/0001140361-24-009930-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124009930/ef20022651_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-009930

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer